down arrow

Max Healthcare

  • Market Cap: Large Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE027H01010
  • NSEID: MAXHEALTH
  • BSEID: 543220
INR
1,092.90
-17.1 (-1.54%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 19.67 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,083.451,119.80

52 Week

743.001,227.50
Valuation
Technical
Day's Volume

CASH

19.67 lacs (20.49%) Volume

Shareholding (Dec 2024)

FII

56.93%

Held by 985 FIIs

DII

15.55%

Held by 101 DIIs

Promoter

23.74%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 35.32% and Operating profit at 93.40%

 
3

The company has declared Negative results for the last 3 consecutive quarters

4

Stock is technically in a Mildly Bullish range

5

With ROE of 12, it has a Very Expensive valuation with a 12.3 Price to Book Value

6

High Institutional Holdings at 72.49%

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 106,245 Cr (Large Cap)

stock-summary
P/E

101.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.14%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

12.03%

stock-summary
Price to Book

12.26

Revenue and Profits (1 Year):
Net Sales:
1,868 Cr
(Quarterly Results - Dec 2024)
Net Profit:
239 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.14%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
16.23%
0%
16.23%
1 Year
26.36%
0.18%
26.54%
2 Years
142.57%
0.52%
143.09%
3 Years
195.06%
0.71%
195.77%
4 Years
398.93%
1.15%
400.08%
5 Years
0%
0%
0.0%

Latest dividend: 1.5 per share ex-dividend date: Aug-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
35.32%
EBIT Growth (5y)
93.40%
EBIT to Interest (avg)
9.54
Debt to EBITDA (avg)
3.83
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.47
Tax Ratio
24.72%
Dividend Payout Ratio
13.78%
Pledged Shares
0
Institutional Holding
72.49%
ROCE (avg)
9.99%
ROE (avg)
11.50%
Valuation key factors
Factor
Value
P/E Ratio
101
Industry P/E
55
Price to Book Value
12.26
EV to EBIT
78.00
EV to EBITDA
63.07
EV to Capital Employed
11.68
EV to Sales
16.57
PEG Ratio
101.29
Dividend Yield
0.14%
ROCE (Latest)
14.15%
ROE (Latest)
12.03%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

FIIs

Pledged Promoter Holdings

None

Mutual Funds

Held by 30 Schemes (11.72%)

FIIs

Held by 985 FIIs (56.93%)

Promoter with highest holding

Abhay Soi (23.73%)

Highest Public shareholder

New World Fund Inc (6.11%)

Individual Investors Holdings

3.13%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 9.42% vs 10.66% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -15.26% vs 19.27% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,868.31",
          "val2": "1,707.46",
          "chgp": "9.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "499.13",
          "val2": "450.54",
          "chgp": "10.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "52.39",
          "val2": "33.54",
          "chgp": "56.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-73.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "238.80",
          "val2": "281.81",
          "chgp": "-15.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.72%",
          "val2": "26.39%",
          "chgp": "0.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 22.74% vs 20.19% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 0.26% vs -18.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,250.41",
          "val2": "2,648.15",
          "chgp": "22.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "837.95",
          "val2": "724.73",
          "chgp": "15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.42",
          "val2": "27.92",
          "chgp": "105.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "518.08",
          "val2": "516.76",
          "chgp": "0.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.78%",
          "val2": "27.37%",
          "chgp": "-1.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 28.51% vs 19.07% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -6.11% vs -5.45% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,118.72",
          "val2": "3,983.12",
          "chgp": "28.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,337.08",
          "val2": "1,110.59",
          "chgp": "20.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "109.81",
          "val2": "39.16",
          "chgp": "180.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-73.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "756.88",
          "val2": "806.10",
          "chgp": "-6.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.12%",
          "val2": "27.88%",
          "chgp": "-1.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 18.49% vs 16.05% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -4.16% vs 82.38% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,406.02",
          "val2": "4,562.60",
          "chgp": "18.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,492.12",
          "val2": "1,240.53",
          "chgp": "20.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "59.89",
          "val2": "83.86",
          "chgp": "-28.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,057.64",
          "val2": "1,103.51",
          "chgp": "-4.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.60%",
          "val2": "27.19%",
          "chgp": "0.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1,868.31
1,707.46
9.42%
Operating Profit (PBDIT) excl Other Income
499.13
450.54
10.78%
Interest
52.39
33.54
56.20%
Exceptional Items
-73.63
0.00
Consolidate Net Profit
238.80
281.81
-15.26%
Operating Profit Margin (Excl OI)
26.72%
26.39%
0.33%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 9.42% vs 10.66% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -15.26% vs 19.27% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
3,250.41
2,648.15
22.74%
Operating Profit (PBDIT) excl Other Income
837.95
724.73
15.62%
Interest
57.42
27.92
105.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
518.08
516.76
0.26%
Operating Profit Margin (Excl OI)
25.78%
27.37%
-1.59%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 22.74% vs 20.19% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 0.26% vs -18.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5,118.72
3,983.12
28.51%
Operating Profit (PBDIT) excl Other Income
1,337.08
1,110.59
20.39%
Interest
109.81
39.16
180.41%
Exceptional Items
-73.63
0.00
Consolidate Net Profit
756.88
806.10
-6.11%
Operating Profit Margin (Excl OI)
26.12%
27.88%
-1.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 28.51% vs 19.07% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -6.11% vs -5.45% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
5,406.02
4,562.60
18.49%
Operating Profit (PBDIT) excl Other Income
1,492.12
1,240.53
20.28%
Interest
59.89
83.86
-28.58%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,057.64
1,103.51
-4.16%
Operating Profit Margin (Excl OI)
27.60%
27.19%
0.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 18.49% vs 16.05% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -4.16% vs 82.38% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Max Healthcare Institute Ltd stock-summary
stock-summary
Max Healthcare Institute Ltd
Large Cap
Hospital & Healthcare Services
Max Healthcare Institute Limited was originally incorporated as "Infinitum Technologies Private Limited" at New Delhi, India as a Private Limited Company dated June 18 ,2001. Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of `Infinitum Technologies Private Limited' was changed to `Max Healthcare Institute Private Limited'.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."